Angiogenesis Technologies, Inc.
Records under this name other than patents Angiogenesis Technologies, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 8 of 8 · Back to Angiogenesis Technologies, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,016,194 | Method and Apparatus for Cooling a Module Portion Formerly held Term ended Term ended Aug 26, 2024 · High confidence | Term ended | Term ended Aug 26, 2024 | High confidence |
| US 7,820,193 | Anti-Angiogenic Compositions and Methods of Use Formerly held Term ended Ended no later than Apr 8, 2015 · Low confidence | Term ended | Ended no later than Apr 8, 2015 | Low confidence |
| US 6,506,411 | Anti-angiogenic compositions and methods of use Formerly held Term ended Ended no later than Sep 15, 2013 · From the USPTO record | Term ended | Ended no later than Sep 15, 2013 | From the USPTO record |
| US 6,544,544 | Anti-Angiogenic Compositions and Methods of Use Formerly held Term ended Ended no later than Jul 19, 2013 · Low confidence | Term ended | Ended no later than Jul 19, 2013 | Low confidence |
| US 6,846,841 | Anti-Angiogenic Compositions and Methods of Use Formerly held Term ended Term ended Jul 19, 2013 · Medium confidence | Term ended | Term ended Jul 19, 2013 | Medium confidence |
| US 5,716,981 | Anti-angiogenic compositions and methods of use Formerly held Term ended Term ended no later than Feb 10, 2018 · Low confidence | Term ended | Term ended no later than Feb 10, 2018 | Low confidence |
| US 5,886,026 | Anti-angiogenic compositions and methods of use Formerly held Term ended Term ended no later than Mar 23, 2019 · Low confidence | Term ended | Term ended no later than Mar 23, 2019 | Low confidence |
| US 5,994,341 | Anti-angiogenic Compositions and methods for the treatment of arthritis Formerly held Term ended Term ended no later than Nov 30, 2019 · Low confidence | Term ended | Term ended no later than Nov 30, 2019 | Low confidence |